ALKEM LABORATORIES share price has plunged 4% and is presently trading at Rs 5,857.5.
Meanwhile, the BSE HEALTHCARE index is at 42,709.7 (down 0.8%).
Among the top losers in the BSE HEALTHCARE index today are Sun Pharma (down 2.8%) and Lupin (down 2.6%).
GSK Pharma (up 2.3%) and GRANULES INDIA (up 2.0%) are among the top gainers today.
Over the last one year, ALKEM LABORATORIES has moved up from Rs 3,531.8 to Rs 5,857.5, registering a gain of Rs 2,325.7 (up 65.9%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 42,709.7, registering a gain of 55.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 215.1%), Glenmark Pharma (up 122.7%) and SUVEN PHARMACEUTICALS (up 119.9%).
Don't Miss: Key Information for Long-term Investors
The BSE Sensex is at 80,082.0 (down 0.2%).
The top losers among the BSE Sensex today are M&M (down 3.0%) and Sun Pharma (down 2.8%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.
In the meantime, NSE Nifty is at 24,436.0 (down 0.2%). M&M and Sun Pharma are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 80,082.0, registering a gain of 15,510.1 points (up 24.0%).
ALKEM LABORATORIES net profit grew 91.2% YoY to Rs 5,502 million for the quarter ended June 2024, compared to a profit of Rs 2,878 million a year ago. Net sales rose 2.2% to Rs 30,318 million during the period as against Rs 29,677 million in April-June 2023.
For the year ended March 2024, ALKEM LABORATORIES reported 79.9% increase in net profit to Rs 18,115 million compared to net profit of Rs 10,068 million during FY23. Revenue of the company grew 9.2% to Rs 126,676 million during FY24.
The current Price to earnings ratio of ALKEM LABORATORIES, based on rolling 12 month earnings, stands at 33.8.
Equitymaster requests your view! Post a comment on "ALKEM LABORATORIES Plunges 4%; BSE HEALTHCARE Index Down 0.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!